Differential in vitro response to octreotide and pasireotide in normal and tumoral primary pituitary cell cultures
Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Raúl M. Luque(Instituto de Salud Carlos III), Arraez Miguel Angel, Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Eva Venegas‐Moreno(Hospital Universitario Virgen del Rocío), Japon Miguel Angel, la Riva Andres de, Esther Rivero‐Cortés(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Laura M. López‐Sánchez(Instituto Maimónides de Investigación Biomédica de Córdoba), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Francisco J. Tinahones(Instituto de Salud Carlos III), Pedro Benito-López(Instituto Maimónides de Investigación Biomédica de Córdoba), Alfonso Soto‐Moreno(Instituto de Biomedicina de Sevilla), Alfonso Leal‐Cerro(Consejo Superior de Investigaciones Científicas), Luis Jiménez‐Reina(University of Córdoba), Herbert Schmid(Novartis (Switzerland)), Silvia Maraver-Selfa(Hospital Clínico Universitario Virgen de la Victoria), Alberto Moreno, María A. Gálvez(Hospital Universitario Reina Sofía), Juan Antonio García-Arnés
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
|Nutrition Reviews|2017|414
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
|International Journal of Epidemiology|2018|325